Table 1 Characteristics of the CML patient's samples
ID | Stage | Karyotype | BCR/ABL1 D-FISH (Interphase FISH) |
|---|---|---|---|
1 | BC | 46,XY,t(9;22)(q34;q11)[3]/47,idem,+der(22)t(9;22)(q34;q11)[7] | NA |
2 | CP | 46,XY,t(9;22)(q34;q11)[7]/47,idem,+der(22)t(9;22)(q34;q11)[7] | NA |
3 | NA | NA | NA |
4 | NA | NA | NA |
5 | NA | NA | NA |
6 | NA | NA | NA |
7 | NA | 46,XY,t(9;22)(q34;q11)/47,XY,idem,der(22)t(9,22)(q34;q11) | NA |
8 | P- SCT | 49,XY,+8,del(9)(q31?q34),t(9;22)(q34;q11),add(21)(q22),+add(21)(q22),+der(22)t(9;22)(q34;q11)[8]/46,XX[3] | 2R2G[87]/1G3F[13]1 |
9 | BC | 46,XY,t(17;22)(q23;q11)t(9;22)(q34;q11)[8]/47,idem,+der(22)t(9;22)(q34;q11)[2]/48-50,idem,+Y,+8,+10,+der(22)t(9;22)(q34;q11)[cp3] | NA |
10 | NA | NA | NA |
11 | R | 47,XY,t(1;22;9)(q21;q11;q34),add(12)(q24),+der(22)t(1;22;9)t(22,?22)(q11;q11)[10] | 1R2G1F[11]/1R2G2F[63]/2R2G[26]2 |
12 | BC | 46,XY[1]/48-49,XY,t(9;22)(q34;q11),+der(22),+8,+8,+8,+8,t(20;21)(q12;q22)[19]inc | 2R2G[210]/1R1G3F[17] |
13 | CP | 46,XY,t(9;22)(q34;q11.2)[12]/47,idem,+der(22)t(9;22)[3] | 2R2G[34]/1R1G2F[6]/1G2F[58]/1G3F[6]1 |
14 | P | NA | Metaphase FISH:2R2G[12]/1R1G2F[5]/1R1 G3F[3] |
15 | AP | 46,XY,t(9;22)(q34;q11)[1]/46,idem,der(19)t(?17;19)(q1?1;p13)[4]/47,idem,+der(22)t(9;22)(q34;q11)[5] | 1R1G2F/1R1G3F |
16 | AP | 46,XY,t(9;22)(q34;q11)[7]/55,idem,+8,+8,+14,+18,+18,+19,+21,+der(22)t(9;22)(q34;q11)[63]/46,XY[1] | NA |
17 | BC- BMT | ?47-53,XY,t(9;22)(q34;q11),+der(22)t(9;22)(q34;q11),+1-7 mar[cp11] | Metaphase FISH: 2R2G[3]/2R1G1F[8]/2R1 G2F[9]3 |
18 | R | NA | 2R2G[67]/1R1G5F[33] |
19 | BC | 46,XY,t(9;22;17;11)(q34;q11.2;q11.2;q13)[2]/46,idem,add(5)(q?)[33]/47,idem,+der(22)t(9;22)(q34;q11)[?] | NA |